Cyfuse Biomedical K.K. (4892.T)

JPY 970.0

(-2.81%)

Net Income Summary of Cyfuse Biomedical K.K.

  • Cyfuse Biomedical K.K.'s latest annual net income in 2023 was -589.21 Million JPY , down -24.32% from previous year.
  • Cyfuse Biomedical K.K.'s latest quarterly net income in 2024 Q2 was -222.93 Million JPY , up 0.6% from previous quarter.
  • Cyfuse Biomedical K.K. reported an annual net income of -473.96 Million JPY in 2022, down -431.66% from previous year.
  • Cyfuse Biomedical K.K. reported an annual net income of 142.9 Million JPY in 2021, up 143.37% from previous year.
  • Cyfuse Biomedical K.K. reported a quarterly net income of -224.27 Million JPY for 2024 Q1, down -310.55% from previous quarter.
  • Cyfuse Biomedical K.K. reported a quarterly net income of -54.62 Million JPY for 2023 Q4, up 67.86% from previous quarter.

Annual Net Income Chart of Cyfuse Biomedical K.K. (2023 - 2020)

Historical Annual Net Income of Cyfuse Biomedical K.K. (2023 - 2020)

Year Net Income Net Income Growth
2023 -589.21 Million JPY -24.32%
2022 -473.96 Million JPY -431.66%
2021 142.9 Million JPY 143.37%
2020 -329.5 Million JPY 0.0%

Peer Net Income Comparison of Cyfuse Biomedical K.K.

Name Net Income Net Income Difference
Pharma Foods International Co., Ltd. 3.2 Billion JPY 118.384%
Takeda Pharmaceutical Company Limited 144.06 Billion JPY 100.409%
Sumitomo Pharma Co., Ltd. -314.96 Billion JPY 99.813%
Shionogi & Co., Ltd. 162.03 Billion JPY 100.364%
Wakamoto Pharmaceutical Co.,Ltd. 108.95 Million JPY 640.764%
Nippon Shinyaku Co., Ltd. 25.85 Billion JPY 102.279%
Kaken Pharmaceutical Co., Ltd. 8.02 Billion JPY 107.342%
Eisai Co., Ltd. 42.4 Billion JPY 101.389%
Morishita Jintan Co., Ltd. 697 Million JPY 184.535%
Hisamitsu Pharmaceutical Co., Inc. 13.96 Billion JPY 104.218%
Mochida Pharmaceutical Co., Ltd. 4.54 Billion JPY 112.958%
Fuso Pharmaceutical Industries,Ltd. 1.37 Billion JPY 142.789%
Nippon Chemiphar Co., Ltd. -180 Million JPY -227.339%
Tsumura & Co. 16.7 Billion JPY 103.527%
Kissei Pharmaceutical Co., Ltd. 11.16 Billion JPY 105.28%
Torii Pharmaceutical Co., Ltd. 4.11 Billion JPY 114.305%
Towa Pharmaceutical Co., Ltd. 16.17 Billion JPY 103.643%
Fuji Pharma Co., Ltd. 3.43 Billion JPY 117.153%
Zeria Pharmaceutical Co., Ltd. 7.73 Billion JPY 107.621%
KYORIN Holdings, Inc. 5.32 Billion JPY 111.071%
Taiko Pharmaceutical Co.,Ltd. -4.89 Billion JPY 87.961%
Daito Pharmaceutical Co.,Ltd. 3.29 Billion JPY 117.882%
SymBio Pharmaceuticals Limited -1.96 Billion JPY 69.981%
MedRx Co., Ltd -932 Million JPY 36.78%
Mizuho Medy Co.,Ltd. 3.77 Billion JPY 115.611%
Solasia Pharma K.K. -1.11 Billion JPY 47.013%
Modalis Therapeutics Corporation -2.39 Billion JPY 75.366%
ASKA Pharmaceutical Holdings Co.,Ltd. 7.54 Billion JPY 107.809%
Sawai Group Holdings Co., Ltd. 13.69 Billion JPY 104.302%
Toho Holdings Co., Ltd. 20.65 Billion JPY 102.852%
Koa Shoji Holdings Co.,Ltd. 2.94 Billion JPY 119.998%